Stay tuned, there is more to come in:
Need more information? Click here to connect with Kurin.
- USPTO Agrees to Kurin’s Request to Review Validity of Magnolia Medical’s ‘483 Patent
- Kurin Receives 510k from the FDA with Indication to Reduce Blood Culture Contaminations
- Kurin Commends the CDC for Their Recent Publication on Blood Culture Contamination
- ENA Welcomes Kurin to 2023 Corporate Engagement Council
- Kurin Announces Kurin Jet, A Quantum Leap Forward in Devices Designed to Address Blood Culture Contamination
- Kurin, Inc. Announces Successful FDA Audit
- Kurin, Inc. Provides Update on Litigation Activity
- Kurin, Inc. Announces Full Scale Manufacturing of Push-button Needle
- U.S. District Court Enters Judgment of No Infringement of Patent Asserted Against Kurin Inc. by Magnolia Medical Technologies, Inc.
- Kurin, Inc. Announces Launch of Its Proprietary Push-button Needle System